We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand the role of BRCA1 and BRCA2 genes in breast cancer risk. Learn about inherited mutations, other risk factors, genetic testing, and proactive management strategies.

Ever wondered if your genes play a role in your health? For many, especially women, the thought of breast cancer can bring up concerns about family history and inherited risks. It’s a topic that touches many lives, and understanding the science behind it can be empowering. Today, we’re going to talk about two key players in this story: the BRCA1 and BRCA2 genes. These aren't just random letters and numbers; they're like the architects of your DNA, usually helping to keep things in order. But when they have certain changes, known as mutations, they can unfortunately increase the risk of developing breast cancer.
Think of your genes as instruction manuals for your body. They tell your cells how to grow, divide, and function. The BRCA1 and BRCA2 genes are like the repair crew for your DNA. Their main job is to fix damage that naturally occurs in your DNA, especially in your breast and ovarian cells. This repair process is vital for preventing cells from growing out of control, which is how cancer can start. When these genes have mutations, their ability to repair DNA is compromised. This can lead to the accumulation of errors in the DNA, making it more likely for cells to develop into cancer.
It’s important to remember that not everyone with a BRCA mutation will develop cancer. Similarly, many people who develop breast cancer do not have a known BRCA mutation. However, having a mutation in BRCA1 or BRCA2 significantly raises your lifetime risk compared to someone without these mutations.
Gene mutations can happen in two main ways: they can be inherited, meaning you're born with them, or they can be acquired later in life due to environmental factors or random errors during cell division. The mutations we're discussing with BRCA1 and BRCA2 are typically inherited. Scientists estimate that about 5% to 10% of all breast cancers are hereditary, meaning they are linked to inherited gene mutations.
The connection between BRCA genes and breast cancer risk is quite direct. When BRCA1 or BRCA2 genes are mutated, they can’t do their job of repairing DNA effectively. This faulty repair mechanism allows damaged cells to survive and multiply. Over time, these abnormal cells can accumulate more genetic errors, leading to uncontrolled growth and eventually forming a tumor.
For women who inherit a BRCA gene mutation, the lifetime risk of developing breast cancer is notably higher. According to the Centers for Disease Control and Prevention (CDC), about 50 out of every 100 women with a BRCA gene mutation will develop breast cancer by age 70. This is significantly higher than the general population. Men can also carry BRCA mutations, and those with a BRCA2 mutation have an increased risk of male breast cancer.
The impact of BRCA1 and BRCA2 mutations isn’t limited to breast cancer alone. Individuals with these mutations also face an elevated risk of developing other types of cancer, including:
This broader impact highlights the critical role these genes play in maintaining cellular health across various tissues.
While BRCA1 and BRCA2 are the most well-known, they are not the only genes that can increase breast cancer risk when mutated. Researchers have identified other genes that, when altered, can also contribute to a higher likelihood of developing the disease. Some of these include:
Understanding these other genes broadens our perspective on the genetic landscape of breast cancer and emphasizes that it's a complex interplay of various genetic factors.
Genetic testing can identify mutations in genes like BRCA1 and BRCA2. However, it’s not recommended for everyone. It’s typically considered for individuals with a strong personal or family history of certain cancers. You might be a good candidate if you have:
It’s essential to discuss your family history and potential eligibility for genetic testing with your doctor or a genetic counselor. They can help you understand the implications and make an informed decision.
Genetic testing for BRCA and other cancer-related genes usually involves a simple blood or saliva sample. This sample is sent to a laboratory where it’s analyzed for specific mutations. The results can take a few weeks to come back. Your doctor or genetic counselor will then discuss the results with you in detail, explaining what they mean for your health and outlining potential next steps.
Receiving a result that indicates a BRCA mutation can be overwhelming. However, knowledge is power. Understanding your increased risk allows you to work closely with your healthcare team to develop a personalized screening and prevention plan. This might include:
It’s also important to maintain a healthy lifestyle. While lifestyle choices can’t eliminate the genetic risk, they can contribute to overall well-being and potentially support cancer prevention efforts. This includes eating a balanced diet, staying physically active, maintaining a healthy weight, limiting alcohol intake, and avoiding smoking.
If you have a significant family history of breast, ovarian, prostate, or pancreatic cancer, or if you’re concerned about your personal risk, don’t hesitate to speak with your doctor. They can assess your situation, discuss the pros and cons of genetic testing, and guide you toward appropriate screening and management strategies. Early awareness and proactive management are key to navigating the complexities of hereditary cancer risk.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026